The annual hazard for recurrence in patients with tumors at least 1 cm in size starts at about 10% per year, decreases over time, and stabilizes at about 4% per year after 6 to 8 years.
In the presence of competing risks, the WLW model models both the marginal hazard for death and the cause-specific hazard for recurrences [ 19].
Kaplan Meyer curves for cumulative hazard of recurrence over 48 h were also drawn.
Analyzing the hazards for disease recurrence or progression over time to determine if the hazard for recurrence has peaked is one way to generate confidence in whether the trial results will change.
The Cox-PH and WLW local recurrence models ignore the hazards for distant recurrence and death, thus resulting in different conclusions for local recurrence when compared to with CR model.
In multivariate regression analysis, the GSTT1positive genotype was the independent predictor for recurrence [hazard ratio (HR), 1.631; p = 0.043] and progression (HR, 3.418; p = 0.006).
These methods were also compared using two simulated examples, scenario A where the hazards for distant recurrence and death were higher in the control group, and scenario B. where the hazards of distant recurrence and death were higher in the experimental group.
In view of these results, it seems remarkable that mir-124-3 mir-124-3 mir-124-3uted high and fairly independent hazards for disease recurrence in our bivariate analyses accounting for the states of distant methylationor locontributedanced disease.
Figure 1 shows the hazard of recurrence for centrally confirmed HER2+ placebo patients.
